{"transactions":[{"id":4631508,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-10-06T00:42:51.000Z","date":"2026-10-01","kind":"exercise","planned":true,"acquired":false,"shares":7667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted for a total of 46,000 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date."}],"balance_after":0,"derivative":{"exercise_price":45.5,"expiration_date":"2026-12-15","underlying":"Class A Common Stock","underlying_shares":7667},"source":{"system":"sec-edgar","filing":"0001193125-26-414725","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1894052/000119312526414725/ownership.xml","form_type":"4"}},{"id":4631507,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2026-10-06T00:42:51.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":836,"price":59.3275,"value":49597.79,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares were sold in multiple transactions at prices ranging from $59.32 to $59.41, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 103,190 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":166803,"source":{"system":"sec-edgar","filing":"0001193125-26-414725","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1894052/000119312526414725/ownership.xml","form_type":"4"}},{"id":4631506,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2026-10-06T00:42:51.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":6831,"price":58.7164,"value":401091.7284,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $58.275 to $59.255, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 103,190 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":167639,"source":{"system":"sec-edgar","filing":"0001193125-26-414725","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1894052/000119312526414725/ownership.xml","form_type":"4"}},{"id":4631505,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2026-10-06T00:42:51.000Z","date":"2026-10-01","kind":"exercise","planned":true,"acquired":true,"shares":7667,"price":45.5,"value":348848.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 103,190 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":174470,"source":{"system":"sec-edgar","filing":"0001193125-26-414725","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894052/000119312526414725/ownership.xml","form_type":"4"}},{"id":4621670,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2026-09-17T21:05:35.000Z","date":"2026-09-15","kind":"grant","planned":false,"acquired":true,"shares":48076,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Award represents a total of 48,076 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 100% of the units shall vest on September 15, 2028, subject to the Reporting Person continuing to be a service provider through such date.  Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 103,190 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":166803,"source":{"system":"sec-edgar","filing":"0001193125-26-394493","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894052/000119312526394493/ownership.xml","form_type":"4"}},{"id":3745,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-09-03T23:33:29.000Z","date":"2026-09-01","kind":"exercise","planned":true,"acquired":false,"shares":7667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted for a total of 46,000 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date."}],"balance_after":7667,"derivative":{"exercise_price":45.5,"expiration_date":"2026-12-15","underlying":"Class A Common Stock","underlying_shares":7667},"source":{"system":"sec-edgar","filing":"0001193125-26-382329","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1894052/000119312526382329/ownership.xml","form_type":"4"}},{"id":3744,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2026-09-03T23:33:29.000Z","date":"2026-09-01","kind":"sale","planned":true,"acquired":false,"shares":7667,"price":61.045,"value":468032.015,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $60.65 to $61.25, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 55,114 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":118727,"source":{"system":"sec-edgar","filing":"0001193125-26-382329","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1894052/000119312526382329/ownership.xml","form_type":"4"}},{"id":3743,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2026-09-03T23:33:29.000Z","date":"2026-09-01","kind":"exercise","planned":true,"acquired":true,"shares":7667,"price":45.5,"value":348848.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 55,114 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":126394,"source":{"system":"sec-edgar","filing":"0001193125-26-382329","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894052/000119312526382329/ownership.xml","form_type":"4"}},{"id":695401,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-08-05T21:11:52.000Z","date":"2026-08-03","kind":"exercise","planned":true,"acquired":false,"shares":7667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted for a total of 46,000 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date."}],"balance_after":15334,"derivative":{"exercise_price":45.5,"expiration_date":"2026-12-15","underlying":"Class A Common Stock","underlying_shares":7667},"source":{"system":"sec-edgar","filing":"0001193125-26-335473","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000119312526335473/ownership.xml","form_type":"4"}},{"id":695400,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2026-08-05T21:11:52.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":6884,"price":60.1075,"value":413780.03,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares were sold in multiple transactions at prices ranging from $59.895 to $60.385, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 55,114 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":118727,"source":{"system":"sec-edgar","filing":"0001193125-26-335473","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000119312526335473/ownership.xml","form_type":"4"}},{"id":695399,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2026-08-05T21:11:52.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":783,"price":59.0343,"value":46223.8569,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $58.89 to $59.46, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 55,114 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":125611,"source":{"system":"sec-edgar","filing":"0001193125-26-335473","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000119312526335473/ownership.xml","form_type":"4"}},{"id":695398,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2026-08-05T21:11:52.000Z","date":"2026-08-03","kind":"exercise","planned":true,"acquired":true,"shares":7667,"price":45.5,"value":348848.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 55,114 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":126394,"source":{"system":"sec-edgar","filing":"0001193125-26-335473","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000119312526335473/ownership.xml","form_type":"4"}},{"id":714796,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-07-06T21:39:45.000Z","date":"2026-07-01","kind":"exercise","planned":true,"acquired":false,"shares":7667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted for a total of 46,000 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date."}],"balance_after":23001,"derivative":{"exercise_price":45.5,"expiration_date":"2026-12-15","underlying":"Class A Common Stock","underlying_shares":7667},"source":{"system":"sec-edgar","filing":"0001193125-26-296456","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000119312526296456/ownership.xml","form_type":"4"}},{"id":714795,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2026-07-06T21:39:45.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":7667,"price":53.2013,"value":407894.3671,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $52.96 to $53.50, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 55,114 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":118727,"source":{"system":"sec-edgar","filing":"0001193125-26-296456","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000119312526296456/ownership.xml","form_type":"4"}},{"id":714794,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2026-07-06T21:39:45.000Z","date":"2026-07-01","kind":"exercise","planned":true,"acquired":true,"shares":7667,"price":45.5,"value":348848.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 55,114 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":126394,"source":{"system":"sec-edgar","filing":"0001193125-26-296456","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000119312526296456/ownership.xml","form_type":"4"}},{"id":751212,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-06-03T20:43:12.000Z","date":"2026-06-01","kind":"exercise","planned":true,"acquired":false,"shares":7666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted for a total of 46,000 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date."}],"balance_after":30668,"derivative":{"exercise_price":45.5,"expiration_date":"2026-12-15","underlying":"Class A Common Stock","underlying_shares":7666},"source":{"system":"sec-edgar","filing":"0001193125-26-255624","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000119312526255624/ownership.xml","form_type":"4"}},{"id":751211,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2026-06-03T20:43:12.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":508,"price":56.16,"value":28529.28,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 55,114 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":118727,"source":{"system":"sec-edgar","filing":"0001193125-26-255624","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000119312526255624/ownership.xml","form_type":"4"}},{"id":751210,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2026-06-03T20:43:12.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":7158,"price":55.5868,"value":397890.3144,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares were sold in multiple transactions at prices ranging from $55.15 to $56.105 , inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. The shares were sold pursuant to a 10b5-1 trading plan adopted on February 3, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 55,114 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":119235,"source":{"system":"sec-edgar","filing":"0001193125-26-255624","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000119312526255624/ownership.xml","form_type":"4"}},{"id":751209,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2026-06-03T20:43:12.000Z","date":"2026-06-01","kind":"exercise","planned":true,"acquired":true,"shares":7666,"price":45.5,"value":348803.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 55,114 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares include 374 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026."}],"balance_after":126393,"source":{"system":"sec-edgar","filing":"0001193125-26-255624","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000119312526255624/ownership.xml","form_type":"4"}},{"id":789604,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-05-06T21:05:57.000Z","date":"2026-05-05","kind":"exercise","planned":true,"acquired":false,"shares":7666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted for a total of 46,000 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date."}],"balance_after":38334,"derivative":{"exercise_price":45.5,"expiration_date":"2026-12-15","underlying":"Class A Common Stock","underlying_shares":7666},"source":{"system":"sec-edgar","filing":"0001193125-26-209338","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000119312526209338/ownership.xml","form_type":"4"}},{"id":789603,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2026-05-06T21:05:57.000Z","date":"2026-05-05","kind":"sale","planned":true,"acquired":false,"shares":738,"price":58.3354,"value":43051.5252,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares were sold in multiple transactions at prices ranging from $58.195 to $58.36, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. The shares were sold pursuant to a 10b5-1 trading plan adopted on February 3, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 55,114 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":118353,"source":{"system":"sec-edgar","filing":"0001193125-26-209338","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000119312526209338/ownership.xml","form_type":"4"}},{"id":789602,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2026-05-06T21:05:57.000Z","date":"2026-05-05","kind":"sale","planned":true,"acquired":false,"shares":6928,"price":57.4708,"value":398157.7024,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $57.16 to $58.05 , inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. The shares were sold pursuant to a 10b5-1 trading plan adopted on February 3, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 55,114 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":119091,"source":{"system":"sec-edgar","filing":"0001193125-26-209338","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000119312526209338/ownership.xml","form_type":"4"}},{"id":789601,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2026-05-06T21:05:57.000Z","date":"2026-05-05","kind":"exercise","planned":true,"acquired":true,"shares":7666,"price":45.5,"value":348803.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 55,114 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":126019,"source":{"system":"sec-edgar","filing":"0001193125-26-209338","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000119312526209338/ownership.xml","form_type":"4"}},{"id":789600,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2026-05-06T21:05:57.000Z","date":"2026-05-04","kind":"sale","planned":true,"acquired":false,"shares":4688,"price":58.465,"value":274083.92,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 55,114 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":118353,"source":{"system":"sec-edgar","filing":"0001193125-26-209338","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000119312526209338/ownership.xml","form_type":"4"}},{"id":919211,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2026-02-04T21:10:44.000Z","date":"2026-02-02","kind":"sale","planned":false,"acquired":false,"shares":6667,"price":64.885,"value":432588.295,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transaction includes 55,114 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":123041,"source":{"system":"sec-edgar","filing":"0001193125-26-037578","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000119312526037578/ownership.xml","form_type":"4"}},{"id":964638,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2025-12-18T02:48:47.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":false,"shares":6825,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 15, 2022 and ending December 10, 2025. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 10,557 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 64.65% of the target award amount resulting in the vesting of 6,825 PSUs. The remaining 3,732 PSUs were cancelled. The service-based vesting component of the PSU award was satisfied upon certification of the achievement of the performance criteria."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 15, 2022 and ending December 10, 2025. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 10,557 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 64.65% of the target award amount resulting in the vesting of 6,825 PSUs. The remaining 3,732 PSUs were cancelled. The service-based vesting component of the PSU award was satisfied upon certification of the achievement of the performance criteria."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":6825},"source":{"system":"sec-edgar","filing":"0001193125-25-323446","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000119312525323446/ownership.xml","form_type":"4"}},{"id":964637,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-18T02:48:47.000Z","date":"2025-12-15","kind":"grant","planned":false,"acquired":true,"shares":56440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"This option was granted for a total of 56,440 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2025, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter."}],"balance_after":56440,"derivative":{"exercise_price":66.62,"expiration_date":"2035-12-15","underlying":"Class A Common Stock","underlying_shares":56440},"source":{"system":"sec-edgar","filing":"0001193125-25-323446","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000119312525323446/ownership.xml","form_type":"4"}},{"id":964636,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2025-12-18T02:48:47.000Z","date":"2025-12-15","kind":"grant","planned":false,"acquired":true,"shares":12816,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each performance-based restricted stock unit (\"PSU\") represents a right to receive, upon vesting, one share of Class A common stock. The vesting of this PSU award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 15, 2025 and ending December 12, 2028 and (ii) satisfaction of a service-based vesting component. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon the later of three years from the date of grant and certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each performance-based restricted stock unit (\"PSU\") represents a right to receive, upon vesting, one share of Class A common stock. The vesting of this PSU award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 15, 2025 and ending December 12, 2028 and (ii) satisfaction of a service-based vesting component. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon the later of three years from the date of grant and certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each performance-based restricted stock unit (\"PSU\") represents a right to receive, upon vesting, one share of Class A common stock. The vesting of this PSU award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 15, 2025 and ending December 12, 2028 and (ii) satisfaction of a service-based vesting component. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon the later of three years from the date of grant and certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."}],"balance_after":12816,"derivative":{"underlying":"Class A Common Stock","underlying_shares":12816},"source":{"system":"sec-edgar","filing":"0001193125-25-323446","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000119312525323446/ownership.xml","form_type":"4"}},{"id":964635,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2025-12-18T02:48:47.000Z","date":"2025-12-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":2612,"price":66.62,"value":174011.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Shares held following the reported transactions include 55,114 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":129708,"source":{"system":"sec-edgar","filing":"0001193125-25-323446","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000119312525323446/ownership.xml","form_type":"4"}},{"id":964634,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2025-12-18T02:48:47.000Z","date":"2025-12-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":8203,"price":67.54,"value":554030.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Shares held following the reported transactions include 60,297 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":132320,"source":{"system":"sec-edgar","filing":"0001193125-25-323446","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000119312525323446/ownership.xml","form_type":"4"}},{"id":964633,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2025-12-18T02:48:47.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":true,"shares":6825,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 74,159 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":140523,"source":{"system":"sec-edgar","filing":"0001193125-25-323446","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000119312525323446/ownership.xml","form_type":"4"}},{"id":964632,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2025-12-18T02:48:47.000Z","date":"2025-12-15","kind":"grant","planned":false,"acquired":true,"shares":25633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Award represents a total of 25,633 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 15, 2025. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 74,159 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":133698,"source":{"system":"sec-edgar","filing":"0001193125-25-323446","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000119312525323446/ownership.xml","form_type":"4"}},{"id":969096,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2025-12-15T22:03:02.000Z","date":"2025-12-11","kind":"sale","planned":true,"acquired":false,"shares":7273,"price":68.75,"value":500018.75,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transaction includes 48,526 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":108065,"source":{"system":"sec-edgar","filing":"0001193125-25-319384","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000119312525319384/ownership.xml","form_type":"4"}},{"id":989774,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2025-11-24T21:44:25.000Z","date":"2025-11-20","kind":"sale","planned":false,"acquired":false,"shares":6164,"price":66.12,"value":407563.68,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transaction includes 48,526 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares include 284 shares and 67 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2025 and November 17, 2025, respectively."}],"balance_after":115338,"source":{"system":"sec-edgar","filing":"0001193125-25-293772","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000119312525293772/ownership.xml","form_type":"4"}},{"id":1155992,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2025-05-07T20:47:24.000Z","date":"2025-05-05","kind":"sale","planned":false,"acquired":false,"shares":675,"price":75.04,"value":50652.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transaction includes 48,526 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":121151,"source":{"system":"sec-edgar","filing":"0000950170-25-065824","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017025065824/ownership.xml","form_type":"4"}},{"id":1326387,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2024-12-19T02:30:12.000Z","date":"2024-12-16","kind":"exercise","planned":false,"acquired":false,"shares":5990,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 15, 2021 and ending December 11, 2024. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 8,513 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 70.37% of the target award amount resulting in the vesting of 5,990 PSUs. The remaining 2,523 PSUs were cancelled. The service-based vesting component of the PSU award was satisfied upon certification of the achievement of the performance criteria."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 15, 2021 and ending December 11, 2024. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 8,513 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 70.37% of the target award amount resulting in the vesting of 5,990 PSUs. The remaining 2,523 PSUs were cancelled. The service-based vesting component of the PSU award was satisfied upon certification of the achievement of the performance criteria."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":5990},"source":{"system":"sec-edgar","filing":"0000950170-24-138170","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017024138170/ownership.xml","form_type":"4"}},{"id":1326386,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-12-19T02:30:12.000Z","date":"2024-12-16","kind":"grant","planned":false,"acquired":true,"shares":36446,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option was granted for a total of 36,446 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 16, 2024, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter."}],"balance_after":36446,"derivative":{"exercise_price":77.91,"expiration_date":"2034-12-16","underlying":"Class A Common Stock","underlying_shares":36446},"source":{"system":"sec-edgar","filing":"0000950170-24-138170","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017024138170/ownership.xml","form_type":"4"}},{"id":1326385,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2024-12-19T02:30:12.000Z","date":"2024-12-16","kind":"grant","planned":false,"acquired":true,"shares":10366,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The vesting of this performance-based restricted stock unit (\"PSU\") award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 16, 2024 and ending December 13, 2027 and (ii) a service-based vesting component to be satisfied upon certification of the achievement of the performance criteria. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The vesting of this performance-based restricted stock unit (\"PSU\") award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 16, 2024 and ending December 13, 2027 and (ii) a service-based vesting component to be satisfied upon certification of the achievement of the performance criteria. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The vesting of this performance-based restricted stock unit (\"PSU\") award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 16, 2024 and ending December 13, 2027 and (ii) a service-based vesting component to be satisfied upon certification of the achievement of the performance criteria. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."}],"balance_after":10366,"derivative":{"underlying":"Class A Common Stock","underlying_shares":10366},"source":{"system":"sec-edgar","filing":"0000950170-24-138170","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017024138170/ownership.xml","form_type":"4"}},{"id":1326384,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2024-12-19T02:30:12.000Z","date":"2024-12-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":11703,"price":79.18,"value":926643.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Shares held following the reported transactions include 48,526 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":121826,"source":{"system":"sec-edgar","filing":"0000950170-24-138170","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017024138170/ownership.xml","form_type":"4"}},{"id":1326383,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2024-12-19T02:30:12.000Z","date":"2024-12-16","kind":"exercise","planned":false,"acquired":true,"shares":5990,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 65,762 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":133529,"source":{"system":"sec-edgar","filing":"0000950170-24-138170","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017024138170/ownership.xml","form_type":"4"}},{"id":1326382,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2024-12-19T02:30:12.000Z","date":"2024-12-16","kind":"grant","planned":false,"acquired":true,"shares":20733,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Award represents a total of 20,733 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 16, 2024. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 65,762 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":127539,"source":{"system":"sec-edgar","filing":"0000950170-24-138170","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017024138170/ownership.xml","form_type":"4"}},{"id":1350730,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-11-26T23:42:43.000Z","date":"2024-11-25","kind":"exercise","planned":true,"acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This performance-based stock option award was granted for a total of 20,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2018 was at 75% of target, or 15,000 shares."}],"balance_after":0,"derivative":{"exercise_price":64.6,"expiration_date":"2025-12-17","underlying":"Class A Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0000950170-24-131191","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017024131191/ownership.xml","form_type":"4"}},{"id":1350729,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-11-26T23:42:43.000Z","date":"2024-11-22","kind":"exercise","planned":true,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This performance-based stock option award was granted for a total of 20,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2018 was at 75% of target, or 15,000 shares."}],"balance_after":7000,"derivative":{"exercise_price":64.6,"expiration_date":"2025-12-17","underlying":"Class A Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0000950170-24-131191","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017024131191/ownership.xml","form_type":"4"}},{"id":1350728,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-11-26T23:42:43.000Z","date":"2024-11-22","kind":"exercise","planned":true,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted for a total of 40,000 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date."}],"balance_after":0,"derivative":{"exercise_price":33.15,"expiration_date":"2025-12-15","underlying":"Class A Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000950170-24-131191","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017024131191/ownership.xml","form_type":"4"}},{"id":1350727,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2024-11-26T23:42:43.000Z","date":"2024-11-25","kind":"sale","planned":true,"acquired":false,"shares":7000,"price":80.5,"value":563500.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 45,029 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":106806,"source":{"system":"sec-edgar","filing":"0000950170-24-131191","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017024131191/ownership.xml","form_type":"4"}},{"id":1350726,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2024-11-26T23:42:43.000Z","date":"2024-11-25","kind":"exercise","planned":true,"acquired":true,"shares":7000,"price":64.6,"value":452200.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 45,029 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":113806,"source":{"system":"sec-edgar","filing":"0000950170-24-131191","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017024131191/ownership.xml","form_type":"4"}},{"id":1350725,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2024-11-26T23:42:43.000Z","date":"2024-11-22","kind":"sale","planned":true,"acquired":false,"shares":48000,"price":80,"value":3840000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 45,029 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":106806,"source":{"system":"sec-edgar","filing":"0000950170-24-131191","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017024131191/ownership.xml","form_type":"4"}},{"id":1350724,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2024-11-26T23:42:43.000Z","date":"2024-11-22","kind":"exercise","planned":true,"acquired":true,"shares":8000,"price":64.6,"value":516800.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 45,029 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":154806,"source":{"system":"sec-edgar","filing":"0000950170-24-131191","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017024131191/ownership.xml","form_type":"4"}},{"id":1350723,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2024-11-26T23:42:43.000Z","date":"2024-11-22","kind":"exercise","planned":true,"acquired":true,"shares":40000,"price":33.15,"value":1326000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 45,029 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":146806,"source":{"system":"sec-edgar","filing":"0000950170-24-131191","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017024131191/ownership.xml","form_type":"4"}},{"id":1350722,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2024-11-26T23:42:43.000Z","date":"2024-11-22","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":81,"value":162000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 45,029 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares include 239 shares and 48 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2024 and November 15, 2024, respectively."}],"balance_after":106806,"source":{"system":"sec-edgar","filing":"0000950170-24-131191","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017024131191/ownership.xml","form_type":"4"}},{"id":1648916,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-02-13T02:24:03.000Z","date":"2024-02-09","kind":"exercise","planned":true,"acquired":false,"shares":21120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The original Form 4 did not report that option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This performance-based stock option award was granted for a total of 23,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2020 was at 96% of target, or 21,120. shares."}],"balance_after":0,"derivative":{"exercise_price":62.32,"expiration_date":"2024-12-15","underlying":"Class A Common Stock","underlying_shares":21120},"source":{"system":"sec-edgar","filing":"0000950170-24-014128","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017024014128/ownership.xml","form_type":"4/A","original_submission_date":"2024-02-12"}},{"id":1648915,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-02-13T02:24:03.000Z","date":"2024-02-09","kind":"exercise","planned":true,"acquired":false,"shares":12440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The original Form 4 did not report that option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted for a total of 62,440 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date."}],"balance_after":0,"derivative":{"exercise_price":42.98,"expiration_date":"2024-12-15","underlying":"Class A Common Stock","underlying_shares":12440},"source":{"system":"sec-edgar","filing":"0000950170-24-014128","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017024014128/ownership.xml","form_type":"4/A","original_submission_date":"2024-02-12"}},{"id":1648914,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-02-13T02:24:03.000Z","date":"2024-02-08","kind":"exercise","planned":true,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The original Form 4 did not report that option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted for a total of 62,440 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date."}],"balance_after":12440,"derivative":{"exercise_price":42.98,"expiration_date":"2024-12-15","underlying":"Class A Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000950170-24-014128","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017024014128/ownership.xml","form_type":"4/A","original_submission_date":"2024-02-12"}},{"id":1648913,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2024-02-13T02:24:03.000Z","date":"2024-02-09","kind":"sale","planned":true,"acquired":false,"shares":33560,"price":80.8074,"value":2711896.344,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The original Form 4 did not report that option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares were sold in multiple transactions at prices ranging from $80.45 to $81.07, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 45,029 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":108519,"source":{"system":"sec-edgar","filing":"0000950170-24-014128","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017024014128/ownership.xml","form_type":"4/A","original_submission_date":"2024-02-12"}},{"id":1648912,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2024-02-13T02:24:03.000Z","date":"2024-02-09","kind":"exercise","planned":true,"acquired":true,"shares":21120,"price":62.32,"value":1316198.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The original Form 4 did not report that option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 45,029 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":142079,"source":{"system":"sec-edgar","filing":"0000950170-24-014128","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017024014128/ownership.xml","form_type":"4/A","original_submission_date":"2024-02-12"}},{"id":1648911,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2024-02-13T02:24:03.000Z","date":"2024-02-09","kind":"exercise","planned":true,"acquired":true,"shares":12440,"price":42.98,"value":534671.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The original Form 4 did not report that option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 45,029 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":120959,"source":{"system":"sec-edgar","filing":"0000950170-24-014128","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017024014128/ownership.xml","form_type":"4/A","original_submission_date":"2024-02-12"}},{"id":1648910,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2024-02-13T02:24:03.000Z","date":"2024-02-08","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":80,"value":4000000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The original Form 4 did not report that option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 45,029 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":108519,"source":{"system":"sec-edgar","filing":"0000950170-24-014128","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017024014128/ownership.xml","form_type":"4/A","original_submission_date":"2024-02-12"}},{"id":1648909,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2024-02-13T02:24:03.000Z","date":"2024-02-08","kind":"exercise","planned":true,"acquired":true,"shares":50000,"price":42.98,"value":2149000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The original Form 4 did not report that option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 45,029 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":158519,"source":{"system":"sec-edgar","filing":"0000950170-24-014128","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017024014128/ownership.xml","form_type":"4/A","original_submission_date":"2024-02-12"}},{"id":1648908,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-02-12T21:45:12.000Z","date":"2024-02-09","kind":"exercise","planned":true,"acquired":false,"shares":21120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This performance-based stock option award was granted for a total of 23,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2020 was at 96% of target, or 21,120. shares."}],"balance_after":0,"derivative":{"exercise_price":62.32,"expiration_date":"2024-12-15","underlying":"Class A Common Stock","underlying_shares":21120},"source":{"system":"sec-edgar","filing":"0000950170-24-013922","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017024013922/ownership.xml","form_type":"4"}},{"id":1648907,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-02-12T21:45:12.000Z","date":"2024-02-09","kind":"exercise","planned":true,"acquired":false,"shares":12440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted for a total of 62,440 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date."}],"balance_after":0,"derivative":{"exercise_price":42.98,"expiration_date":"2024-12-15","underlying":"Class A Common Stock","underlying_shares":12440},"source":{"system":"sec-edgar","filing":"0000950170-24-013922","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017024013922/ownership.xml","form_type":"4"}},{"id":1648906,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-02-12T21:45:12.000Z","date":"2024-02-08","kind":"exercise","planned":true,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted for a total of 62,440 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date."}],"balance_after":12440,"derivative":{"exercise_price":42.98,"expiration_date":"2024-12-15","underlying":"Class A Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000950170-24-013922","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017024013922/ownership.xml","form_type":"4"}},{"id":1648905,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2024-02-12T21:45:12.000Z","date":"2024-02-09","kind":"sale","planned":true,"acquired":false,"shares":33560,"price":80.8074,"value":2711896.344,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $80.45 to $81.07, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 45,029 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":108519,"source":{"system":"sec-edgar","filing":"0000950170-24-013922","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017024013922/ownership.xml","form_type":"4"}},{"id":1648904,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2024-02-12T21:45:12.000Z","date":"2024-02-09","kind":"exercise","planned":true,"acquired":true,"shares":21120,"price":62.32,"value":1316198.4,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 45,029 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":142079,"source":{"system":"sec-edgar","filing":"0000950170-24-013922","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017024013922/ownership.xml","form_type":"4"}},{"id":1648903,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2024-02-12T21:45:12.000Z","date":"2024-02-09","kind":"exercise","planned":true,"acquired":true,"shares":12440,"price":42.98,"value":534671.2,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 45,029 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":120959,"source":{"system":"sec-edgar","filing":"0000950170-24-013922","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017024013922/ownership.xml","form_type":"4"}},{"id":1648902,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2024-02-12T21:45:12.000Z","date":"2024-02-08","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":80,"value":4000000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 45,029 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":108519,"source":{"system":"sec-edgar","filing":"0000950170-24-013922","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017024013922/ownership.xml","form_type":"4"}},{"id":1648901,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2024-02-12T21:45:12.000Z","date":"2024-02-08","kind":"exercise","planned":true,"acquired":true,"shares":50000,"price":42.98,"value":2149000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 45,029 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":158519,"source":{"system":"sec-edgar","filing":"0000950170-24-013922","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017024013922/ownership.xml","form_type":"4"}},{"id":1704502,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2023-12-20T00:34:29.000Z","date":"2023-12-15","kind":"exercise","planned":false,"acquired":false,"shares":5427,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 15, 2020 and ending December 12, 2023. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 6,750 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 80.41% of the target award amount resulting in the vesting of 5,427 PSUs. The remaining 1,323 PSUs were cancelled.  The service-based vesting component of the PSU award was satisfied upon certification of the achievement of the performance criteria."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 15, 2020 and ending December 12, 2023. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 6,750 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 80.41% of the target award amount resulting in the vesting of 5,427 PSUs. The remaining 1,323 PSUs were cancelled.  The service-based vesting component of the PSU award was satisfied upon certification of the achievement of the performance criteria."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":5427},"source":{"system":"sec-edgar","filing":"0001209191-23-059260","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919123059260/doc4.xml","form_type":"4"}},{"id":1704501,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-12-20T00:34:29.000Z","date":"2023-12-15","kind":"grant","planned":false,"acquired":true,"shares":30327,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"This option was granted for a total of 30,327 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2023, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter."}],"balance_after":30327,"derivative":{"exercise_price":87.49,"expiration_date":"2033-12-15","underlying":"Class A Common Stock","underlying_shares":30327},"source":{"system":"sec-edgar","filing":"0001209191-23-059260","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919123059260/doc4.xml","form_type":"4"}},{"id":1704500,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2023-12-20T00:34:29.000Z","date":"2023-12-15","kind":"grant","planned":false,"acquired":true,"shares":8651,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"The vesting of this performance-based restricted stock unit (\"PSU\") award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 15, 2023 and ending December 10, 2026 and (ii) a service-based vesting component to be satisfied upon certification of the achievement of the performance criteria. Each PSU represents a right to receive, upon vesting, one share of Class A common stock.  The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The vesting of this performance-based restricted stock unit (\"PSU\") award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 15, 2023 and ending December 10, 2026 and (ii) a service-based vesting component to be satisfied upon certification of the achievement of the performance criteria. Each PSU represents a right to receive, upon vesting, one share of Class A common stock.  The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The vesting of this performance-based restricted stock unit (\"PSU\") award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 15, 2023 and ending December 10, 2026 and (ii) a service-based vesting component to be satisfied upon certification of the achievement of the performance criteria. Each PSU represents a right to receive, upon vesting, one share of Class A common stock.  The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."}],"balance_after":8651,"derivative":{"underlying":"Class A Common Stock","underlying_shares":8651},"source":{"system":"sec-edgar","filing":"0001209191-23-059260","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919123059260/doc4.xml","form_type":"4"}},{"id":1704499,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2023-12-20T00:34:29.000Z","date":"2023-12-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":1488,"price":87.49,"value":130185.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Shares held following the reported transactions include 45,029 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":108519,"source":{"system":"sec-edgar","filing":"0001209191-23-059260","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919123059260/doc4.xml","form_type":"4"}},{"id":1704498,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2023-12-20T00:34:29.000Z","date":"2023-12-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":9093,"price":88.6,"value":805639.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Shares held following the reported transactions include 48,029 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":110007,"source":{"system":"sec-edgar","filing":"0001209191-23-059260","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919123059260/doc4.xml","form_type":"4"}},{"id":1704497,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2023-12-20T00:34:29.000Z","date":"2023-12-15","kind":"exercise","planned":false,"acquired":true,"shares":5427,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 60,939 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":119100,"source":{"system":"sec-edgar","filing":"0001209191-23-059260","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919123059260/doc4.xml","form_type":"4"}},{"id":1704496,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2023-12-20T00:34:29.000Z","date":"2023-12-15","kind":"grant","planned":false,"acquired":true,"shares":17303,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Award represents a total of 17,303 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 15, 2023. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 60,939 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":113673,"source":{"system":"sec-edgar","filing":"0001209191-23-059260","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919123059260/doc4.xml","form_type":"4"}},{"id":1736353,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2023-11-17T21:10:41.000Z","date":"2023-11-15","kind":"sale","planned":false,"acquired":false,"shares":79,"price":88.58,"value":6997.82,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transaction include 43,636 restricted stock units, which are subject to forfeiture until they vest."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares include (1) 87 shares acquired under the Issuer's Employee Stock Purchase Plan on November 15, 2021, (2) 38 shares acquired under the Issuer's Employee Stock Purchase Plan on November 15, 2022, and (3) 79 shares acquired under the Issuer's Employee Stock Purchase Plan on November 15, 2023.  The shares acquired on November 15, 2021 and November 15, 2022 were not included in share totals reported previously due to administrative error."}],"balance_after":96370,"source":{"system":"sec-edgar","filing":"0001209191-23-055721","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919123055721/doc4.xml","form_type":"4"}},{"id":1891164,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2023-05-16T21:12:20.000Z","date":"2023-05-15","kind":"sale","planned":false,"acquired":false,"shares":278,"price":83.87,"value":23315.86,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 43,636 restricted stock units, which are subject to forfeiture until they vest."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares include 278 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2023."}],"balance_after":96245,"source":{"system":"sec-edgar","filing":"0001209191-23-029860","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919123029860/doc4.xml","form_type":"4"}},{"id":2026297,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-02-09T02:24:36.000Z","date":"2023-02-07","kind":"exercise","acquired":false,"shares":21850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This performance-based stock option award was granted for a total of 23,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2019 was at 95% of target, or 21,850 shares."}],"balance_after":0,"derivative":{"exercise_price":45.5,"expiration_date":"2023-12-15","underlying":"Class A Common Stock","underlying_shares":21850},"source":{"system":"sec-edgar","filing":"0001209191-23-007946","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919123007946/doc4.xml","form_type":"4"}},{"id":2026296,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-02-09T02:24:36.000Z","date":"2023-02-07","kind":"exercise","acquired":false,"shares":15153,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option was granted for a total of 65,153 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date."}],"balance_after":0,"derivative":{"exercise_price":37.35,"expiration_date":"2023-12-16","underlying":"Class A Common Stock","underlying_shares":15153},"source":{"system":"sec-edgar","filing":"0001209191-23-007946","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919123007946/doc4.xml","form_type":"4"}},{"id":2026295,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-02-09T02:24:36.000Z","date":"2023-02-06","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option was granted for a total of 65,153 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date."}],"balance_after":15153,"derivative":{"exercise_price":37.35,"expiration_date":"2023-12-16","underlying":"Class A Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-23-007946","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919123007946/doc4.xml","form_type":"4"}},{"id":2026294,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2023-02-09T02:24:36.000Z","date":"2023-02-07","kind":"sale","acquired":false,"shares":5801,"price":84.3701,"value":489430.9501,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $84.26 to $84.67. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 43,636 restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":96245,"source":{"system":"sec-edgar","filing":"0001209191-23-007946","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919123007946/doc4.xml","form_type":"4"}},{"id":2026293,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2023-02-09T02:24:36.000Z","date":"2023-02-07","kind":"sale","acquired":false,"shares":31202,"price":83.8615,"value":2616646.523,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $83.26 to $84.25. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 43,636 restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":102046,"source":{"system":"sec-edgar","filing":"0001209191-23-007946","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919123007946/doc4.xml","form_type":"4"}},{"id":2026292,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2023-02-09T02:24:36.000Z","date":"2023-02-07","kind":"exercise","acquired":true,"shares":21850,"price":45.5,"value":994175.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 43,636 restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":133248,"source":{"system":"sec-edgar","filing":"0001209191-23-007946","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919123007946/doc4.xml","form_type":"4"}},{"id":2026291,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2023-02-09T02:24:36.000Z","date":"2023-02-07","kind":"exercise","acquired":true,"shares":15153,"price":37.35,"value":565964.55,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 43,636 restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":111398,"source":{"system":"sec-edgar","filing":"0001209191-23-007946","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919123007946/doc4.xml","form_type":"4"}},{"id":2026290,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2023-02-09T02:24:36.000Z","date":"2023-02-06","kind":"sale","acquired":false,"shares":8262,"price":85.24,"value":704252.88,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares were sold in multiple transactions at prices ranging from $85.04 to $85.91. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 43,636 restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":96245,"source":{"system":"sec-edgar","filing":"0001209191-23-007946","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919123007946/doc4.xml","form_type":"4"}},{"id":2026289,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2023-02-09T02:24:36.000Z","date":"2023-02-06","kind":"sale","acquired":false,"shares":41738,"price":84.4842,"value":3526201.5396,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $84.03 to $85.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 43,636 restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":104507,"source":{"system":"sec-edgar","filing":"0001209191-23-007946","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919123007946/doc4.xml","form_type":"4"}},{"id":2026288,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2023-02-09T02:24:36.000Z","date":"2023-02-06","kind":"exercise","acquired":true,"shares":50000,"price":37.35,"value":1867500.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 43,636 restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":146245,"source":{"system":"sec-edgar","filing":"0001209191-23-007946","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919123007946/doc4.xml","form_type":"4"}},{"id":2081307,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2022-12-20T02:40:48.000Z","date":"2022-12-16","kind":"exercise","acquired":false,"shares":4858,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 16, 2019 and ending December 13, 2022. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 6,000 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400\nIndex at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 80.98% of the target award amount resulting in the vesting of 4,858 PSUs. The remaining 1,142 PSUs were cancelled."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 16, 2019 and ending December 13, 2022. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 6,000 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400\nIndex at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 80.98% of the target award amount resulting in the vesting of 4,858 PSUs. The remaining 1,142 PSUs were cancelled."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":4858},"source":{"system":"sec-edgar","filing":"0001209191-22-062076","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919122062076/doc4.xml","form_type":"4"}},{"id":2081306,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-12-20T02:40:48.000Z","date":"2022-12-15","kind":"grant","acquired":true,"shares":38013,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"This option was granted for a total of 38,013 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2022, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter."}],"balance_after":38013,"derivative":{"exercise_price":71.07,"expiration_date":"2031-12-15","underlying":"Class A Common Stock","underlying_shares":38013},"source":{"system":"sec-edgar","filing":"0001209191-22-062076","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919122062076/doc4.xml","form_type":"4"}},{"id":2081305,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2022-12-20T02:40:48.000Z","date":"2022-12-15","kind":"grant","acquired":true,"shares":10557,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"The vesting of this performance-based restricted stock unit (\"PSU\") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2022 and ending December 10, 2025. Each PSU represents a right to receive, upon vesting, one share of Class A common stock.  The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The vesting of this performance-based restricted stock unit (\"PSU\") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2022 and ending December 10, 2025. Each PSU represents a right to receive, upon vesting, one share of Class A common stock.  The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The vesting of this performance-based restricted stock unit (\"PSU\") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2022 and ending December 10, 2025. Each PSU represents a right to receive, upon vesting, one share of Class A common stock.  The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."}],"balance_after":10557,"derivative":{"underlying":"Class A Common Stock","underlying_shares":10557},"source":{"system":"sec-edgar","filing":"0001209191-22-062076","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919122062076/doc4.xml","form_type":"4"}},{"id":2081304,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2022-12-20T02:40:48.000Z","date":"2022-12-19","kind":"tax_withholding","acquired":false,"shares":1240,"price":70.8,"value":87792.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Shares held following the reported transactions include 43,636 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":96245,"source":{"system":"sec-edgar","filing":"0001209191-22-062076","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919122062076/doc4.xml","form_type":"4"}},{"id":2081303,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2022-12-20T02:40:48.000Z","date":"2022-12-16","kind":"tax_withholding","acquired":false,"shares":3897,"price":71.07,"value":276959.79,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Shares held following the reported transactions include 46,136 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":97485,"source":{"system":"sec-edgar","filing":"0001209191-22-062076","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919122062076/doc4.xml","form_type":"4"}},{"id":2081302,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2022-12-20T02:40:48.000Z","date":"2022-12-16","kind":"exercise","acquired":true,"shares":4858,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Shares held following the reported transactions include 49,136 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":101382,"source":{"system":"sec-edgar","filing":"0001209191-22-062076","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919122062076/doc4.xml","form_type":"4"}},{"id":2081301,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2022-12-20T02:40:48.000Z","date":"2022-12-15","kind":"grant","acquired":true,"shares":21114,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F3","text":"Award represents a total of 21,114 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 15, 2022. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Shares held following the reported transactions include 49,136 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":96524,"source":{"system":"sec-edgar","filing":"0001209191-22-062076","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919122062076/doc4.xml","form_type":"4"}},{"id":2081300,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2022-12-20T02:40:48.000Z","date":"2022-12-15","kind":"tax_withholding","acquired":false,"shares":3785,"price":73.17,"value":276948.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 28,022 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":75410,"source":{"system":"sec-edgar","filing":"0001209191-22-062076","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919122062076/doc4.xml","form_type":"4"}},{"id":2104997,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2022-11-23T20:55:53.000Z","date":"2022-11-21","kind":"sale","acquired":false,"shares":40,"price":69.02,"value":2760.8,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 35,653 restricted stock units, which are subject to forfeiture until they vest."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares include 38 shares acquired under the Issuer's Employee Stock Purchase Plan on November 15, 2022."}],"balance_after":79195,"source":{"system":"sec-edgar","filing":"0001209191-22-058595","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919122058595/doc4.xml","form_type":"4"}},{"id":2141987,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-10-05T22:53:52.000Z","date":"2022-10-04","kind":"exercise","acquired":false,"shares":4300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This performance-based stock option award was granted for a total of 20,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2018 was at 125% of target, or 25,000 shares."}],"balance_after":0,"derivative":{"exercise_price":33.15,"expiration_date":"2022-12-15","underlying":"Class A Common Stock","underlying_shares":4300},"source":{"system":"sec-edgar","filing":"0001209191-22-052892","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919122052892/doc4.xml","form_type":"4"}},{"id":2141986,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-10-05T22:53:52.000Z","date":"2022-10-03","kind":"exercise","acquired":false,"shares":20700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This performance-based stock option award was granted for a total of 20,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2018 was at 125% of target, or 25,000 shares."}],"balance_after":4300,"derivative":{"exercise_price":33.15,"expiration_date":"2022-12-15","underlying":"Class A Common Stock","underlying_shares":20700},"source":{"system":"sec-edgar","filing":"0001209191-22-052892","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919122052892/doc4.xml","form_type":"4"}},{"id":2141985,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-10-05T22:53:52.000Z","date":"2022-10-03","kind":"exercise","acquired":false,"shares":29300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option was granted for a total of 49,300 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on each anniversary of December 21, 2012, the vesting commencement date."}],"balance_after":0,"derivative":{"exercise_price":30.49,"expiration_date":"2022-12-21","underlying":"Class A Common Stock","underlying_shares":29300},"source":{"system":"sec-edgar","filing":"0001209191-22-052892","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919122052892/doc4.xml","form_type":"4"}},{"id":2141984,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2022-10-05T22:53:52.000Z","date":"2022-10-04","kind":"sale","acquired":false,"shares":4300,"price":67.7213,"value":291201.59,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $67.20 to $67.945. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 35,653 restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":79235,"source":{"system":"sec-edgar","filing":"0001209191-22-052892","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919122052892/doc4.xml","form_type":"4"}},{"id":2141983,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2022-10-05T22:53:52.000Z","date":"2022-10-04","kind":"exercise","acquired":true,"shares":4300,"price":33.15,"value":142545.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 35,653 restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":83535,"source":{"system":"sec-edgar","filing":"0001209191-22-052892","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919122052892/doc4.xml","form_type":"4"}},{"id":2141982,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":2519,"kind":"person","name":"Couling John D","position":1,"cik":"0001894052","reported_name":"Couling John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Entertainment"}}],"security":"Class A Common Stock","published_at":"2022-10-05T22:53:52.000Z","date":"2022-10-03","kind":"sale","acquired":false,"shares":12020,"price":65.8143,"value":791087.886,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $65.69 to $65.91. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 35,653 restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":79235,"source":{"system":"sec-edgar","filing":"0001209191-22-052892","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919122052892/doc4.xml","form_type":"4"}}],"next_cursor":"2022-10-05T22:53:52.000000Z,2141982"}